<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/E1649C06-DC81-4A08-8A23-F5B65BB6C670"><gtr:id>E1649C06-DC81-4A08-8A23-F5B65BB6C670</gtr:id><gtr:name>Babraham Institute</gtr:name><gtr:department>UNLISTED</gtr:department><gtr:address><gtr:line1>Babraham Research Campus</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB22 3AT</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E1649C06-DC81-4A08-8A23-F5B65BB6C670"><gtr:id>E1649C06-DC81-4A08-8A23-F5B65BB6C670</gtr:id><gtr:name>Babraham Institute</gtr:name><gtr:address><gtr:line1>Babraham Research Campus</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB22 3AT</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/1286F5C5-1A66-4C2C-A87A-64DC5E8514E4"><gtr:id>1286F5C5-1A66-4C2C-A87A-64DC5E8514E4</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:surname>Gaunt</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BBS%2FE%2FB%2F0000C162"><gtr:id>9CC75EF4-BA51-4B4E-94CD-64730F992465</gtr:id><gtr:title>The role of Cdx protein phosphorylation in colorectal carcinoma cells</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>BBS/E/B/0000C162</gtr:grantReference><gtr:abstractText>Cdx1 and Cdx2 are proteins that regulate the normal growth and differentiation (specialisation) of the intestinal epithelium (the outer layer of cells of the intestine). Both proteins are suppressed in colorectal carcinoma (CRC) and it is believed that this contributes to the progression of malignancy. We have shown that degradation of Cdx2 protein in CRC cells is signalled by its prior phosphorylation (the addition of phosphate). We have also shown that Cdx1 is phosphorylated and we next intend to examine whether this is a signal for degradation or activation of the Cdx1 protein. Our findings will have additional value since Cdx1 and 2 are also important regulators of the developing embryonic axis.</gtr:abstractText><gtr:fund><gtr:end>2012-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2009-04-01</gtr:start><gtr:type>EXPENDITURE_PROJECTED</gtr:type><gtr:valuePounds>164581</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>Production of a scientific paper which enhances understanding of the role of chemotherapeutic agents in colorectal carcinoma.</gtr:description><gtr:firstYearOfImpact>2009</gtr:firstYearOfImpact><gtr:id>B987357C-4C7C-484D-8453-1766D6C85908</gtr:id><gtr:impactTypes><gtr:impactType>Cultural,Societal</gtr:impactType></gtr:impactTypes><gtr:outcomeId>546367cd5f90f6.40997433</gtr:outcomeId><gtr:sector>Education,Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>The Cdx2 protein is widely thought to function as a tumour suppresser, opposing development of colorectal carcinoma. We show that downregulation of Cdx2 in carcinogenesis depends a hyper-active Raf-MEK-ERK1/2 signaling pathway. This 1) reduces Cdx2 transcription, and 2) promotes Cdx2 phosphorylation and proteasome-dependent degradation.</gtr:description><gtr:exploitationPathways>Findings contribute to an understanding of chemotherapy in regard to colorectal carcinoma</gtr:exploitationPathways><gtr:id>F57C5AC3-4FAA-47F5-B479-E31748893F4D</gtr:id><gtr:outcomeId>54636714ebf1d8.91263026</gtr:outcomeId><gtr:sectors><gtr:sector>Education,Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors><gtr:url>http://www.zoo.cam.ac.uk/directory/stephen-gaunt-dr</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>1523A7E5-159B-40CE-B8DE-3F916617F3A3</gtr:id><gtr:title>Down-regulation of Cdx2 in colorectal carcinoma cells by the Raf-MEK-ERK 1/2 pathway.</gtr:title><gtr:parentPublicationTitle>Cellular signalling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/46a902e582fb7153cd3ccf4f16a341bc"><gtr:id>46a902e582fb7153cd3ccf4f16a341bc</gtr:id><gtr:otherNames>Krueger F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0898-6568</gtr:issn><gtr:outcomeId>54621b31554939.37906919</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BBS/E/B/0000C162</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>